MSFT and TVGNW Related Headlines
Go Back- Tevogen.AI expands Microsoft, Databricks ties for cancer model beta
- Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
- Tevogen develops AI model to accelerate immunotherapy research
- Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
- Tevogen receives international patent publication for AI peptide prediction technology
- Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
- Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
MSFT and TVGNW Related Press Releases
Go Back- Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
- Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
- Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
- Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
